Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00801138 · ClinicalTrials.gov registry record · NA
The Effect of Dexamethasone on the Duration of Interscalene Nerve Blocks With Ropivacaine or Bupivacaine
A NA study, sponsored by The Cleveland Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 218
- Enrollment target
NCT00801138 is a NA study that was terminated before completion, run by The Cleveland Clinic. The registered enrollment target is 218 participants.
The verdict
NCT00801138, a NA study, was terminated before completion, sponsored by The Cleveland Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 218 participants
- Enrollment target
Study Summary
This study will test the hypothesis that adding dexamethasone significantly prolongs the duration of ropivacaine and bupivacaine analgesia, and that the magnitude of the effect differs among the two local anaesthetics.. Participants will be patients undergoing shoulder surgery with an interscalene nerve block.
Interventions
- DRUG Bupivacaine
- DRUG Dexamethasone
- DRUG saline
- DRUG ropivacaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 218 participants |
| Start Date | 2008-11 |
| Est. Completion | 2010-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00801138
The ClinicalTrials.gov registry entry for NCT00801138 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 218 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Bupivacaine is the first listed.
NCT00801138 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00801138 about?
NCT00801138 is a clinical study titled "The Effect of Dexamethasone on the Duration of Interscalene Nerve Blocks With Ropivacaine or Bupivacaine". This study will test the hypothesis that adding dexamethasone significantly prolongs the duration of ropivacaine and bupivacaine analgesia, and that the magnitude of the effect differs among the two local anaesthetics.. Participants will be patients undergoing shoulder surgery with an interscalene n...
What is the current status of trial NCT00801138?
This trial is currently terminated. It is a NA study. The enrollment target is 218 participants. The study started on 2008-11. Estimated completion is 2010-11.
What interventions are being tested in trial NCT00801138?
The interventions under investigation include: Bupivacaine (DRUG), Dexamethasone (DRUG), saline (DRUG), ropivacaine (DRUG).
Who is sponsoring clinical trial NCT00801138?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.